...
首页> 外文期刊>Journal of Ginseng Research >Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism
【24h】

Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism

机译:人参热处理及糖尿病肾损害:有效成分和作用机理

获取原文
           

摘要

Diabetic nephropathy is one of the serious complications in patients with either type 1 or 2 diabetes mellitus but current treatments remain unsatisfactory. Results of clinical research studies demonstrate that Panax ginseng can help adjust blood pressure and reduce blood sugar and may be advantageous in the treatment of tuberculosis and kidney damage in people with diabetes. The heat-processing method to strengthen the efficacy of P. ginseng has been well-defined based on a long history of ethnopharmacological evidence. The protective effects of P. ginseng on pathological conditions and renal damage associated with diabetic nephropathy in the animal models were markedly improved by heat-processing. The concentrations of less-polar ginsenosides (20( S )-Rg3, 20( R )-Rg3, Rg5, and Rk1) and maltol in P. ginseng were significantly increased in a heat-processing temperature-dependent manner. Based on researches in animal models of diabetes, ginsenoside 20( S )-Rg3 and maltol were evaluated to have therapeutic potential against diabetic renal damage. These effects were achieved through the inhibition of inflammatory pathway activated by oxidative stress and advanced glycation endproducts. These findings indicate that ginsenoside 20( S )-Rg3 and maltol are important bioactive constituents of heat-processed ginseng in the control of pathological conditions associated with diabetic nephropathy. Keywords: Panax ginseng , Heat-processing, 20( S )-Rg3, Advanced glycation endproducts, Free radical.
机译:糖尿病性肾病是1型或2型糖尿病患者的严重并发症之一,但目前的治疗仍然不能令人满意。临床研究结果表明,人参可以帮助调节血压和降低血糖,并且可能在治疗糖尿病人的肺结核和肾脏损害方面具有优势。基于悠久的民族药理学证据,已经明确定义了增强人参功效的热处理方法。通过热处理,人参对动物模型的病理状况和与糖尿病肾病相关的肾脏损害的保护作用得到了明显改善。人参青蒿素中低极性人参皂苷(20(S)-Rg3、20(R)-Rg3,Rg5和Rk1)和麦芽酚的浓度以依赖温度的方式显着增加。基于对糖尿病动物模型的研究,人参皂苷20(S)-Rg3和麦芽酚被评估具有治疗糖尿病肾损害的潜力。这些作用是通过抑制由氧化应激和晚期糖基化终产物激活的炎症途径来实现的。这些发现表明人参皂苷20(S)-Rg3和麦芽酚是热加工人参在控制与糖尿病性肾病相关的病理状态中的重要生物活性成分。关键字:人参,热处理,20(S)-Rg3,高级糖化终产物,自由基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号